{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T19:58:27Z","timestamp":1775159907574,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,3,29]],"date-time":"2014-03-29T00:00:00Z","timestamp":1396051200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s00198-014-2662-0","type":"journal-article","created":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T21:21:20Z","timestamp":1396041680000},"page":"1677-1684","source":"Crossref","is-referenced-by-count":31,"title":["Incident long-term warfarin use and risk of osteoporotic fractures: propensity-score matched cohort of elders with new onset atrial fibrillation"],"prefix":"10.1007","volume":"25","author":[{"given":"D.","family":"Misra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Peloquin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. K.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. P.","family":"Kiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Neogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,29]]},"reference":[{"key":"2662_CR1","doi-asserted-by":"crossref","first-page":"C1336","DOI":"10.1152\/ajpcell.00452.2009","volume":"297","author":"A Rubinacci","year":"2009","unstructured":"Rubinacci A (2009) Expanding the functional spectrum of vitamin K in bone. Focus on: \u201cVitamin K promotes mineralization, osteoblast to osteocyte transition, and an anti-catabolic phenotype by {gamma}-carboxylation-dependent and-independent mechanisms\u201d. Am J Physiol Cell Physiol 297:C1336\u2013C1338","journal-title":"Am J Physiol Cell Physiol"},{"key":"2662_CR2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/03008208909049995","volume":"21","author":"PA Price","year":"1989","unstructured":"Price PA (1989) Gla-containing proteins of bone. Connect Tissue Res 21:51\u201357, discussion 7\u201360","journal-title":"Connect Tissue Res"},{"key":"2662_CR3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0083-6729(08)60061-8","volume":"42","author":"PA Price","year":"1985","unstructured":"Price PA (1985) Vitamin K-dependent formation of bone Gla protein (osteocalcin) and its function. Vitam Horm 42:65\u2013108","journal-title":"Vitam Horm"},{"key":"2662_CR4","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1182\/blood.V93.6.1798.406k22_1798_1808","volume":"93","author":"B Furie","year":"1999","unstructured":"Furie B, Bouchard BA, Furie BC (1999) Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid. Blood 93:1798\u20131808","journal-title":"Blood"},{"key":"2662_CR5","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ajcn\/77.2.512","volume":"77","author":"SL Booth","year":"2003","unstructured":"Booth SL, Broe KE, Gagnon DR et al (2003) Vitamin K intake and bone mineral density in women and men. Am J Clin Nutr 77:512\u2013516","journal-title":"Am J Clin Nutr"},{"key":"2662_CR6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0020-7292(96)02790-7","volume":"56","author":"T Kanai","year":"1997","unstructured":"Kanai T, Takagi T, Masuhiro K, Nakamura M, Iwata M, Saji F (1997) Serum vitamin K level and bone mineral density in post-menopausal women. Int J Gynaecol Obstet 56:25\u201330","journal-title":"Int J Gynaecol Obstet"},{"key":"2662_CR7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/ajcn\/69.1.74","volume":"69","author":"D Feskanich","year":"1999","unstructured":"Feskanich D, Weber P, Willett WC, Rockett H, Booth SL, Colditz GA (1999) Vitamin K intake and hip fractures in women: a prospective study. Am J Clin Nutr 69:74\u201379","journal-title":"Am J Clin Nutr"},{"key":"2662_CR8","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/jbmr.5650081012","volume":"8","author":"SJ Hodges","year":"1993","unstructured":"Hodges SJ, Akesson K, Vergnaud P, Obrant K, Delmas PD (1993) Circulating levels of vitamins K1 and K2 decreased in elderly women with hip fracture. J Bone Miner Res 8:1241\u20131245","journal-title":"J Bone Miner Res"},{"key":"2662_CR9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3945\/an.112.001834","volume":"3","author":"CM Gundberg","year":"2012","unstructured":"Gundberg CM, Lian JB, Booth SL (2012) Vitamin K-dependent carboxylation of osteocalcin: friend or foe? Adv Nutr 3:149\u2013157","journal-title":"Adv Nutr"},{"key":"2662_CR10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/8756-3282(96)00037-3","volume":"18","author":"P Szulc","year":"1996","unstructured":"Szulc P, Chapuy MC, Meunier PJ, Delmas PD (1996) Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. Bone 18:487\u2013488","journal-title":"Bone"},{"key":"2662_CR11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s001980070086","volume":"11","author":"H Luukinen","year":"2000","unstructured":"Luukinen H, Herala M, Koski K, Honkanen R, Laippala P, Kivela SL (2000) Fracture risk associated with a fall according to type of fall among the elderly. Osteoporos Int 11:631\u2013634","journal-title":"Osteoporos Int"},{"key":"2662_CR12","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.7326\/0003-4819-111-12-1001","volume":"111","author":"MH Knapen","year":"1989","unstructured":"Knapen MH, Hamulyak K, Vermeer C (1989) The effect of vitamin K supplementation on circulating osteocalcin (bone Gla protein) and urinary calcium excretion. Ann Intern Med 111:1001\u20131005","journal-title":"Ann Intern Med"},{"key":"2662_CR13","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1359\/jbmr.2000.15.5.872","volume":"15","author":"A Haffa","year":"2000","unstructured":"Haffa A, Krueger D, Bruner J et al (2000) Diet- or warfarin-induced vitamin K insufficiency elevates circulating undercarboxylated osteocalcin without altering skeletal status in growing female rats. J Bone Miner Res 15:872\u2013878","journal-title":"J Bone Miner Res"},{"key":"2662_CR14","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1021\/bi00601a003","volume":"17","author":"DS Whitlon","year":"1978","unstructured":"Whitlon DS, Sadowski JA, Suttie JW (1978) Mechanism of coumarin action: significance of vitamin K epoxide reductase inhibition. Biochemistry 17:1371\u20131377","journal-title":"Biochemistry"},{"key":"2662_CR15","doi-asserted-by":"crossref","first-page":"829","DOI":"10.7326\/0003-4819-128-10-199805150-00006","volume":"128","author":"SA Jamal","year":"1998","unstructured":"Jamal SA, Browner WS, Bauer DC, Cummings SR (1998) Warfarin use and risk for osteoporosis in elderly women. Study of Osteoporotic Fractures Research Group. Ann Intern Med 128:829\u2013832","journal-title":"Ann Intern Med"},{"key":"2662_CR16","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1001\/archinte.159.15.1750","volume":"159","author":"PJ Caraballo","year":"1999","unstructured":"Caraballo PJ, Heit JA, Atkinson EJ et al (1999) Long-term use of oral anticoagulants and the risk of fracture. Arch Intern Med 159:1750\u20131756","journal-title":"Arch Intern Med"},{"key":"2662_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1592\/phco.23.1.1.31922","volume":"23","author":"M Mamdani","year":"2003","unstructured":"Mamdani M, Upshur RE, Anderson G, Bartle BR, Laupacis A (2003) Warfarin therapy and risk of hip fracture among elderly patients. Pharmacotherapy 23:1\u20134","journal-title":"Pharmacotherapy"},{"key":"2662_CR18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/pds.888","volume":"13","author":"D Pilon","year":"2004","unstructured":"Pilon D, Castilloux AM, Dorais M, LeLorier J (2004) Oral anticoagulants and the risk of osteoporotic fractures among elderly. Pharmacoepidemiol Drug Saf 13:289\u2013294","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2662_CR19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archinte.166.2.241","volume":"166","author":"BF Gage","year":"2006","unstructured":"Gage BF, Birman-Deych E, Radford MJ, Nilasena DS, Binder EF (2006) Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2. Arch Intern Med 166:241\u2013246","journal-title":"Arch Intern Med"},{"key":"2662_CR20","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1532-5415.2008.01786.x","volume":"56","author":"C Woo","year":"2008","unstructured":"Woo C, Chang LL, Ewing SK, Bauer DC (2008) Single-point assessment of warfarin use and risk of osteoporosis in elderly men. J Am Geriatr Soc 56:1171\u20131176","journal-title":"J Am Geriatr Soc"},{"key":"2662_CR21","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/ncpendmet0274","volume":"2","author":"R Eastell","year":"2006","unstructured":"Eastell R (2006) Nat Clin Pract Endocrinol Metab 2:484\u2013485","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2662_CR22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000256650","volume":"29","author":"Y Sato","year":"2010","unstructured":"Sato Y, Honda Y, Jun I (2010) Long-term oral anticoagulation therapy and the risk of hip fracture in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation. Cerebrovasc Dis 29:73\u201378","journal-title":"Cerebrovasc Dis"},{"key":"2662_CR23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijcard.2006.07.022","volume":"118","author":"L Rejnmark","year":"2007","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L (2007) Fracture risk in users of oral anticoagulants: a nationwide case\u2013control study. Int J Cardiol 118:338\u2013344","journal-title":"Int J Cardiol"},{"key":"2662_CR24","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/aje\/kwr301","volume":"175","author":"G Danaei","year":"2012","unstructured":"Danaei G, Tavakkoli M, Hernan MA (2012) Bias in observational studies of prevalent users: lessons for comparative effectiveness research from a meta-analysis of statins. Am J Epidemiol 175:250\u2013262","journal-title":"Am J Epidemiol"},{"key":"2662_CR25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1532-5415.2000.tb03917.x","volume":"48","author":"AGS Clinical Practices Committee. American Geriatric Society","year":"2000","unstructured":"AGS Clinical Practices Committee. American Geriatric Society (2000) The use of oral anticoagulants (warfarin) in older people. J Am Geriatr Soc 48:224\u2013227","journal-title":"J Am Geriatr Soc"},{"key":"2662_CR26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.14236\/jhi.v12i3.124","volume":"12","author":"A Bourke","year":"2004","unstructured":"Bourke A, Dattani H, Robinson M (2004) Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care 12:171\u2013177","journal-title":"Inform Prim Care"},{"key":"2662_CR27","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","volume":"17","author":"R D\u2019Agostino Jr","year":"1998","unstructured":"D\u2019Agostino R Jr (1998) Tutorial in biostatistics: propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17:2265\u20132281","journal-title":"Stat Med"},{"key":"2662_CR28","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/pds.1062","volume":"14","author":"JD Seeger","year":"2005","unstructured":"Seeger JD, Williams PL, Walker AM (2005) An application of propensity score matching using claims data. Pharmacoepidemiol Drug Saf 14:465\u2013476","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2662_CR29","first-page":"A36","volume":"60","author":"L Soriano","year":"2011","unstructured":"Soriano L (2011) A UK primary care study on acid-suppressive drugs and hip fracture: is there a link? Gut 60:A36","journal-title":"Gut"},{"key":"2662_CR30","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","volume":"296","author":"YX Yang","year":"2006","unstructured":"Yang YX, Lewis JD, Epstein S, Metz DC (2006) Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 296:2947\u20132953","journal-title":"JAMA"},{"key":"2662_CR31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00223-006-0021-7","volume":"79","author":"P Vestergaard","year":"2006","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2006) Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Calcif Tissue Int 79:76\u201383","journal-title":"Calcif Tissue Int"},{"key":"2662_CR32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1503\/cmaj.071330","volume":"179","author":"L Targownik","year":"2008","unstructured":"Targownik L, Lix L, Metge C, Prior H, Leung S, Leslie W (2008) Use of proton pump inhibitors and risk of osteoporosis-related fractures. CMAJ 179:319\u2013326","journal-title":"CMAJ"},{"key":"2662_CR33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000111997","volume":"25","author":"DL Brown","year":"2008","unstructured":"Brown DL, Morgenstern LB, Majersik JJ, Kleerekoper M, Lisabeth LD (2008) Risk of fractures after stroke. Cerebrovasc Dis 25:95\u201399","journal-title":"Cerebrovasc Dis"},{"key":"2662_CR34","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1161\/01.STR.32.3.702","volume":"32","author":"J Kanis","year":"2001","unstructured":"Kanis J, Oden A, Johnell O (2001) Acute and long-term increase in fracture risk after hospitalization for stroke. Stroke 32:702\u2013706","journal-title":"Stroke"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-014-2662-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-014-2662-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-014-2662-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:02:25Z","timestamp":1597622545000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-014-2662-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,29]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["2662"],"URL":"https:\/\/doi.org\/10.1007\/s00198-014-2662-0","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,29]]}}}